欧盟法规
ECHA物质ECHA物质C&L通报REACH预注册上下游产品
CAS号75-52-5 硝基甲烷 | CAS号71481-64-6 methanol with f... | CAS号50-00-0 甲醛 | CAS号74612-09-2 N-(2-iodobenzyl... | CAS号3156-73-8 2-Propanol, 1-nitro | CAS号1794-90-7 2-Nitro-1,3-pro... | CAS号3164-73-6 1-硝甲基环己醇 | CAS号52-51-7 溴硝丙二醇 | CAS号623-11-0 对硝基甲苯 | CAS号464-10-8 三溴硝基甲烷 | CAS号52-51-7 溴硝丙二醇 | CAS号20820-44-4 hydroxy-[2-nitr... | CAS号3048-73-5 4-nitro-2,6,7-t... | CAS号77-86-1 三(羟甲基)氨基甲烷 | CAS号76-39-1 2-甲基-2-硝基-1-丙醇 | CAS号115-69-5 2-氨基-2-甲基-1,3-丙... | CAS号32051-21-1 (3-tert-butyl-5... | CAS号1794-90-7 2-Nitro-1,3-pro... | CAS号13245-65-3 1,3-dichloro-2-...合成工艺路线路线简述
- 合成目标产物 Tris(Hydroxymethyl)Nitromethane 主要起始原料 Nitromethane And Methanol With Formaldehyde
- (文献来源)合成步骤主要原料 Nitromethane 和 Methanol With Formaldehyde
聚合甲醛,1-Ethoxy-3-Nitro-Propan-2-Ol置于potassium Carbonate体系中,化学反应生成三羟甲基硝基甲烷
参考文献:Charlton; Kenner,Journal Of The Chemical Society,1932,P. 752
标题:Charlton; Kenner,Journal Of The Chemical Society,1932,P. 752
海关参考信息
- 2905121000-正丙醇
2905399001-1,3-丙二醇
2922110001-单乙醇胺
2905141000-异丁醇 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-8304409-B2
优先权日:2002-07-03
标 题:Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
发明人:EARL RICHARD A; EZAWA MAIKO; FANG XINQIN; GARVEY DAVID S; GASTON RICKY D; KHANAPURE SUBHASH P; LETTS L GORDON; LIN CHIA-EN; RANATUNGE RAMANI R; RICHARDSON STEWART K; SCHROEDER JOSEPH D; STEVENSON CHERI A; WEY SHIOW-JYI
权利人:EARL RICHARD A; EZAWA MAIKO; FANG XINQIN; GARVEY DAVID S; GASTON RICKY D; KHANAPURE SUBHASH P; LETTS L GORDON; LIN CHIA-EN; RANATUNGE RAMANI R; RICHARDSON STEWART K; SCHROEDER JOSEPH D; STEVENSON CHERI A; WEY SHIOW-JYI; NICOX SA
摘要:The invention describes novel nitrosated nonsteroidal antiinflammatory drugs (NSAIDs) and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated NSAID, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one nitrosated NSAID, and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one nitrosated NSAID, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating inflammation, pain and fever; for treating gastrointestinal disorders; for facilitating wound healing; for treating and/or preventing gastrointestinal, renal and/or respiratory toxicities resulting from the use of nonsteroidal antiinflammatory compounds; for treating inflammatory disease states and/or disorders; and for treating and/or preventing ophthalmic diseases and/or disorders.
专利号:US-9006347-B2
优先权日:2011-09-08
标 题 :Method of synthesising polycarbonates in the presence of a bimetallic catalyst and a chain transfer agent
发明人:WILLIAMS CHARLOTTE K; KEMBER MICHAEL; BUCHARD ANTOINE; JUTZ FABIAN
权利人:IMP INNOVATIONS LTD
摘要:The invention provides a process for the synthesis of a polycarbonate, the process comprising the step of reacting carbon dioxide with at least one epoxide in the presence of a catalyst of formula (I) and a chain transfer agent. The invention also provides a polymerization system for the copolymerization of carbon dioxide and at least one epoxide comprising a catalyst of formula (I) and a chain transfer agent, polycarbonates produced by the inventive process, a block copolymer comprising a polycarbonate produced by the inventive process, and a method of producing the block copolymer. The invention also relates to novel catalysts of formula (III).
专利号:US-9670134-B2
优先权日:2013-03-28
标 题:Synthesis of (2-nitro)alkyl (meth)acrylates via transesterification of (meth)acrylate esters
发明人:SATHIOSATHAM MUHUNTHAN; WILCZYNSKI ROBERT
权利人:ANGUS CHEMICAL
摘要:Provided is a process for making (2-nitro)alkyl (meth)acrylate compounds of formula I: wherein n, R, R 1 , R 2 , R 3 , R 4 , R 6 , R 7 , and n are as defined herein, by a transesterification reaction between a nitroalcohol compound and a (meth)acrylate compound in the presence of a transesterification catalyst and a free radical inhibitor.
专利号:US-5336784-A
优先权日:1993-06-07
标题:Synthesis of 1,3,3-trinitroazetidine
发明人:HISKEY MICHAEL A; COBURN MICHAEL D
权利人:UNIV CALIFORNIA
摘要:A process of preparing 1,3,3-trinitroazetidine including forming a 5-hydroxymethyl-5-nitro-1-alkyltetrahydro-1,3-oxazine, e.g., reacting a 1,3,5-trialkyl hexahydrotriazine and tris(hydroxymethyl)nitromethane, ring opening said 5-hydroxymethyl-5-nitro-1-alkyltetrahydro-1,3-oxazine to form a 3-alkylamino-2-hydroxymethyl-2-nitro-1-propanol salt, ring closing said 3-alkylamino-2-hydroxymethyl-2-nitro-1-propanol salt to form a 3-hydroxymethyl-3-nitro-1-alkylazetidine salt, nitrating said 3-hydroxymethyl-3-nitro-1-alkylazetidine salt to form a 1-alkyl-3,3-dinitroazetidine, and converting said 1-alkyl-3,3-dinitroazetidine into 1,3,3-trinitroazetidine is disclosed.
专利号:US-7829729-B2
优先权日:2008-05-28
标题 :1-glycidyl-3,3-dinitroazetidine containing explosive moiety and preparation method thereof
发明人:KOWN YOUNG-HWAN; KIM JIN-SEUK; KIM HYOUN-SOO
权利人:AGENCY DEFENSE DEV
摘要:Disclosed is a 1-glycidyl-3,3-dinitroazetidine(GDNAZ) of Formula I wherein dinitroazetidine group which is a high energy group having unit structure of explosive moiety is incorporated to a monomer, and the method thereof. By using the GDNAZ of the present invention in the synthesis of energetic binder for high-performance insensitive explosive, an energetic binder with enhanced thermal and storing stability and explosive power can be provided.
专利号:DE-112014001664-T5
优先权日:2013-03-28
标题:Synthesis of (2-nitro) alkyl (meth) acrylates by transesterification of (meth) acrylate esters